Prior work demonstrates that 5-fluorouracil, a thymidylate synthase inhibitor, sensitizes NSCLC KRAS mutants to apoptosis via the TRAIL-mediated pathway [34]. Here, KRAS is linked to non-small cell lung carcinoma.